semaglutide lowers risk of heart issues regardless of weight loss Benefits Not Tied to Semaglutide and the Heart: clinical

The Lack of Fit value, representing the discrepancy between the model and the observed data, is determined to be not significant with a p-value of 0.1142

Comprehensive primary care services with Louisiana-licensed physicians

(2025, August 18)

The BCBS Federal Employee Program moved GLP-1s to non-covered formulary tiers

More patients receiving Ozempic 0.5 mg (3.1%) and Ozempic 1 mg (3.8%) discontinued treatment due to gastrointestinal adverse reactions compared to placebo (0.4%). Lower-Burp Alternative Treatments For patients who cannot tolerate semaglutide due to persistent sulfur burps or other gastrointestinal side effects, alternative GLP-1 medications or weight loss medications may offer better tolerability

Its not perfect, but its sustainable financially and psychologically for me